| Dr Zeina Aw Dajani, MD | |
|
4500 E 9th Ave Ste 640, Denver, CO 80220-3925 | |
| (303) 280-2008 | |
| (303) 351-7893 |
| Full Name | Dr Zeina Aw Dajani |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 17 Years |
| Location | 4500 E 9th Ave Ste 640, Denver, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295924454 | NPI | - | NPPES |
| Entity Name | Sorkin Dermatology Associates Professional Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578584652 PECOS PAC ID: 0840204269 Enrollment ID: O20060206000394 |
News Archive
There is only scant scientific evidence available on whether the genetic risk for developing specific psychiatric disorders or cognitive traits is manifest in brain structure from childhood and, to date, studies have focused primarily on adult populations. The question remains unanswered.
The Premier healthcare alliance is urging that, if scheduled 2 percent cuts take effect, they not apply to hospitals that have already reduced costs.
Sanofi Pasteur, the vaccines division of Sanofi, announced today that it has filed a Supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) for a quadrivalent formulation of its Fluzone (Influenza Virus Vaccine).
One key problem with treating people with Alzheimer's disease (AD) is the fact that it is often very difficult to detect the disease when it is in the early stages of progression. A team of researchers from the University of the West of England are about to embark on a preliminary study to investigate the efficacy of combining biomarkers in blood with cognitive testing as a way of screening for AD early on so that appropriate treatments can be offered to patients sooner.
› Verified 1 days ago
| Entity Name | Denver Skin Doctors, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679047120 PECOS PAC ID: 0749521599 Enrollment ID: O20190404002469 |
News Archive
There is only scant scientific evidence available on whether the genetic risk for developing specific psychiatric disorders or cognitive traits is manifest in brain structure from childhood and, to date, studies have focused primarily on adult populations. The question remains unanswered.
The Premier healthcare alliance is urging that, if scheduled 2 percent cuts take effect, they not apply to hospitals that have already reduced costs.
Sanofi Pasteur, the vaccines division of Sanofi, announced today that it has filed a Supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) for a quadrivalent formulation of its Fluzone (Influenza Virus Vaccine).
One key problem with treating people with Alzheimer's disease (AD) is the fact that it is often very difficult to detect the disease when it is in the early stages of progression. A team of researchers from the University of the West of England are about to embark on a preliminary study to investigate the efficacy of combining biomarkers in blood with cognitive testing as a way of screening for AD early on so that appropriate treatments can be offered to patients sooner.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zeina Aw Dajani, MD 1938 S Gilpin St, Denver, CO 80210-3308 Ph: (612) 743-7970 | Dr Zeina Aw Dajani, MD 4500 E 9th Ave Ste 640, Denver, CO 80220-3925 Ph: (303) 280-2008 |
News Archive
There is only scant scientific evidence available on whether the genetic risk for developing specific psychiatric disorders or cognitive traits is manifest in brain structure from childhood and, to date, studies have focused primarily on adult populations. The question remains unanswered.
The Premier healthcare alliance is urging that, if scheduled 2 percent cuts take effect, they not apply to hospitals that have already reduced costs.
Sanofi Pasteur, the vaccines division of Sanofi, announced today that it has filed a Supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) for a quadrivalent formulation of its Fluzone (Influenza Virus Vaccine).
One key problem with treating people with Alzheimer's disease (AD) is the fact that it is often very difficult to detect the disease when it is in the early stages of progression. A team of researchers from the University of the West of England are about to embark on a preliminary study to investigate the efficacy of combining biomarkers in blood with cognitive testing as a way of screening for AD early on so that appropriate treatments can be offered to patients sooner.
› Verified 1 days ago
Drew Michael Taylor, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3773 E Cherry Creek North Dr Ste 970, Denver, CO 80209 Phone: 303-388-5629 | |
Dr. William J Bowman, MD Dermatology Medicare: Medicare Enrolled Practice Location: 3464 S Willow St, Suite 194, Denver, CO 80231 Phone: 303-755-2900 Fax: 303-745-7997 | |
Samantha J Lewis, CRNP Dermatology Medicare: Accepting Medicare Assignments Practice Location: 777 Bannock St, Denver, CO 80204 Phone: 303-602-6196 | |
Dr. Patricia A Sinoway, MD Dermatology Medicare: Medicare Enrolled Practice Location: 10350 E Dakota Ave, Denver, CO 80247 Phone: 303-338-4545 | |
Dr. Elisa Suzanne Kapler, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2045 N Franklin St, Denver, CO 80205 Phone: 303-338-4545 | |
Dr. Brian Woodford Petersen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1375 E 20th Ave, Denver, CO 80205 Phone: 303-338-4545 | |
Dr. Neil J Silverman, MD Dermatology Medicare: Medicare Enrolled Practice Location: 10350 E Dakota Ave, Denver, CO 80247 Phone: 303-338-4545 |